CD79A and COVID-19: Despite the high incidence of COVID-19, contact with an infected person was reported only by four JIA patients (all of them tested positive for SARS-CoV-2 IgG and IgA antibodies), with three having a history of COVID-19 diagnoses confirmed by RT PCR test.